Blue Chip Stocks Growth Stocks Undervalued Stocks

The Next Wave of ASX Breakouts: Here are 7 Stocks Best Positioned to Follow the Leaders

Everyone is looking for the next wave of ASX breakouts because they happen in every market cycle. Investors still look back at those stories as proof that the ASX can…

ByNick Sundich

16

Dec 2025

Biotech Stocks

Cynata Therapeutics Completes Phase 2 Enrollment- Buy Before June or Wait for the Data?

Cynata Therapeutics (ASX: CYP) has completed patient enrollment in its Phase 2 clinical trial of a stem cell treatment called CYP-001 for acute graft versus host disease (aGvHD), a potentially…

ByUjjwal Maheshwari

27

Aug 2025

Healthcare Stocks Life Sciences

Here are 5 ASX biotechs expecting clinical trial results in the next few months!

Here are 5 ASX biotechs expecting clinical trial results in the next few months! Dimerix (ASX:DXB) Dimerix is in the middle of a Phase III trial or its DMX-200 drug…

ByNick Sundich

The Next Wave of ASX Breakouts: Here are 7 Stocks Best Positioned to Follow the Leaders

Cynata Therapeutics Completes Phase 2 Enrollment- Buy Before June or Wait for the Data?

Here are 5 ASX biotechs expecting clinical trial results in the next few months!

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

The Next Wave of ASX Breakouts: Here are 7 Stocks Best Positioned to Follow the Leaders

Cynata Therapeutics Completes Phase 2 Enrollment- Buy Before June or Wait for the Data?

Here are 5 ASX biotechs expecting clinical trial results in the next few months!

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Add Your Heading Text Here